Table of Contents Author Guidelines Submit a Manuscript
HPB Surgery
Volume 2012 (2012), Article ID 176723, 8 pages
http://dx.doi.org/10.1155/2012/176723
Review Article

Ischemia/Reperfusion Injury in Liver Surgery and Transplantation: Pathophysiology

1Department of Gastroenterology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, D-93053 Regensburg, Germany
2Department of Gastroenterology, University Hospital Heidelberg, D-69120 Heidelberg, Germany
3Department of General and Transplant Surgery, University Hospital Heidelberg, D-69120 Heidelberg, Germany

Received 18 February 2012; Accepted 5 April 2012

Academic Editor: John J. Lemasters

Copyright © 2012 Kilian Weigand et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. de Groot and U. Rauen, “Ischemia-reperfusion injury: processes in pathogenetic networks: a review,” Transplantation Proceedings, vol. 39, no. 2, pp. 481–484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. I. Kim, “Ischemia-reperfusion injury of the human liver during hepatic resection,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 10, no. 3, pp. 195–199, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. G. D. Rushing and L. D. Britt, “Reperfusion injury after hemorrhage: a collective review,” Annals of Surgery, vol. 247, no. 6, pp. 929–937, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Birrer, Y. Takuda, and T. Takara, “Hypoxic hepatopathy: pathophysiology and prognosis,” Internal Medicine, vol. 46, no. 14, pp. 1063–1070, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Nickkholgh, M. Barro-Bejarano, R. Liang et al., “Signs of reperfusion injury following CO2 pneumoperitoneum: an in vivo microscopy study,” Surgical Endoscopy and Other Interventional Techniques, vol. 22, no. 1, pp. 122–128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. W. Kupiec-Weglinski and R. W. Busuttil, “Ischemia and reperfusion injury in liver transplantation,” Transplantation Proceedings, vol. 37, no. 4, pp. 1653–1656, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Liang, H. Bruns, M. Kincius et al., “Danshen protects liver grafts from ischemia/reperfusion injury in experimental liver transplantation in rats,” Transplant International, vol. 22, no. 11, pp. 1100–1109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Fan, R. M. Zwacka, and J. F. Engelhardt, “Therapeutic approaches for ischemia/reperfusion injury in the liver,” Journal of Molecular Medicine, vol. 77, no. 8, pp. 577–592, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. R. M. Zwacka, W. Zhou, Y. Zhang et al., “Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-κB activation,” Nature Medicine, vol. 4, no. 6, pp. 698–704, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. C. C. Caldwell, T. Okaya, A. Martignoni, T. Husted, R. Schuster, and A. B. Lentsch, “Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion,” American Journal of Physiology, vol. 289, no. 5, pp. G969–G976, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. I. N. Hines, J. M. Hoffman, H. Scheerens et al., “Regulation of postischemic liver injury following different durations of ischemia,” American Journal of Physiology, vol. 284, no. 3, pp. G536–G545, 2003. View at Google Scholar · View at Scopus
  12. T. L. Husted and A. B. Lentsch, “The role of cytokines in pharmacological modulation of hepatic ischemia/reperfusion injury,” Current Pharmaceutical Design, vol. 12, no. 23, pp. 2867–2873, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. K. Pine, A. Aldouri, A. L. Young et al., “Liver transplantation following donation after cardiac death: an analysis using matched pairs,” Liver Transplantation, vol. 15, no. 9, pp. 1072–1082, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Takeuchi, H. Yoshidome, H. Kurosawa et al., “Interleukin-18 exacerbates pulmonary injury after hepatic ischemia/reperfusion in mice,” Journal of Surgical Research, vol. 158, no. 1, pp. 87–93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. A. Weinbroum, A. Kidron, E. Hochhauser, A. Hochman, V. Rudick, and B. A. Vidne, “Liver glutathione level influences myocardial reperfusion injury following liver ischemia-reperfusion,” Medical Science Monitor, vol. 7, no. 6, pp. 1137–1144, 2001. View at Google Scholar · View at Scopus
  16. M. Behrends, R. Hirose, Y. H. Park et al., “Remote renal injury following partial hepatic ischemia/reperfusion injury in rats,” Journal of Gastrointestinal Surgery, vol. 12, no. 3, pp. 490–495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. A. Weinbroum, “N-acetyl-L-cysteine mitigates aortic tone injury following liver ischemia-reperfusion,” Journal of Cardiovascular Pharmacology, vol. 45, no. 6, pp. 509–515, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Okaya, J. Blanchard, R. Schuster et al., “Age-dependent responses to hepatic ischemia/reperfusion injury,” Shock, vol. 24, no. 5, pp. 421–427, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Yokoyama, M. Nagino, and Y. Nimura, “Which gender is better positioned in the process of liver surgery? Male or female?” Surgery Today, vol. 37, no. 10, pp. 823–830, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Manekeller, M. Sioutis, A. Hirner, and T. Minor, “Influence of neoadjuvant chemotherapy on liver integrity and ischemic tolerance,” Zeitschrift fur Gastroenterologie, vol. 46, no. 1, pp. 17–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Schemmer, A. Nickkholgh, U. Hinz et al., “Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis,” Transplantation Proceedings, vol. 39, no. 2, pp. 529–534, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Vollmar and M. D. Menger, “Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences,” Langenbeck's Archives of Surgery, vol. 396, no. 1, pp. 13–29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Schindler, M. Kincius, R. Liang et al., “Fundamental efforts toward the development of a therapeutic cocktail with a manifold ameliorative effect on hepatic ischemia/reperfusion injury,” Microcirculation, vol. 16, no. 7, pp. 593–602, 2009. View at Google Scholar · View at Scopus
  24. Z. Zhong, H. D. Connor, M. Froh et al., “Free radical-dependent dysfunction of small-for-size rat liver grafts: prevention by plant polyphenols,” Gastroenterology, vol. 129, no. 2, pp. 652–664, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Eipel, K. Abshagen, and B. Vollmar, “Regulation of hepatic blood flow: the hepatic arterial buffer response revisited,” World Journal of Gastroenterology, vol. 16, no. 48, pp. 6046–6057, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Seizner, N. Seizmer, W. Jochum, R. Graf, and P. A. Clavien, “Increased ischemic injury in old mouse liver: an ATP-dependent mechanism,” Liver Transplantation, vol. 13, no. 3, pp. 382–390, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Froh, M. D. Wheeler, O. Smutney, Z. Zhong, B. U. Bradford, and R. G. Thurman, “New method of delivering gene-altered Kupffer cells to rat liver: studies in an ischemia-reperfusion model,” Gastroenterology, vol. 124, no. 1, pp. 172–183, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Jaeschke, “Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions,” American Journal of Physiology, vol. 290, no. 6, pp. G1083–G1088, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. A. M. Lefer and D. J. Lefer, “II. Nitric oxide protects in intestinal inflammation,” American Journal of Physiology, vol. 276, no. 3, pp. G572–G575, 1999. View at Google Scholar · View at Scopus
  30. M. B. Grisham, D. N. Granger, and D. J. Lefer, “Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease,” Free Radical Biology and Medicine, vol. 25, no. 4-5, pp. 404–433, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Phillips, A. H. Toledo, F. Lopez-Neblina, R. Anaya-Prado, and L. H. Toledo-Pereyra, “Nitric oxide mechanism of protection in ischemia and reperfusion injury,” Journal of Investigative Surgery, vol. 22, no. 1, pp. 46–55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Abe, I. Hines, G. Zibari, and M. B. Grisham, “Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury,” Archives of Biochemistry and Biophysics, vol. 484, no. 2, pp. 232–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Contaldo, A. Elsherbiny, N. Lindenblatt et al., “Erythropoietin enhances oxygenation in critically perfused tissue through modulation of nitric oxide synthase,” Shock, vol. 31, no. 6, pp. 599–606, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Abu-Amara, S. Y. Yang, A. Seifalian, B. Davidson, and B. Fuller, “The nitric oxide pathway—evidence and mechanisms for protection against liver ischaemia reperfusion injury,” Liver International, vol. 32, pp. 531–543, 2012. View at Google Scholar
  35. H. Jaeschke, “Role of reactive oxygen species in hepatic ischemia-reperfusion injury and preconditioning,” Journal of Investigative Surgery, vol. 16, no. 3, pp. 127–140, 2003. View at Google Scholar · View at Scopus
  36. H. Urakami, Y. Abe, and M. B. Grisham, “Role of reactive metabolites of oxygen and nitrogen in partial liver transplantation: lessons learned from reduced-size liver ischaemia and reperfusion injury,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 9, pp. 912–919, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Abu-Amara, S. Y. Yang, N. Tapuria, B. Fuller, B. Davidson, and A. Seifalian, “Liver ischemia/reperfusion injury: processes in inflammatory networks—a review,” Liver Transplantation, vol. 16, no. 9, pp. 1016–1032, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. E. E. Montalvo-Jave, T. Escalante-Tattersfield, J. A. Ortega-Salgado, E. Piña, and D. A. Geller, “Factors in the pathophysiology of the liver ischemia-reperfusion injury,” Journal of Surgical Research, vol. 147, no. 1, pp. 153–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Belous, C. Knox, I. B. Nicoud et al., “Reversed activity of mitochondrial adenine nucleotide translocator in ischemia-reperfusion,” Transplantation, vol. 75, no. 10, pp. 1717–1723, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. F. López-Neblina, L. H. Toledo-Pereyra, A. H. Toledo, and J. Walsh, “Ryanodine receptor antagonism protects the ischemic liver and modulates TNF-α and IL-10,” Journal of Surgical Research, vol. 140, no. 1, pp. 121–128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. B. A. Miller, “The role of TRP channels in oxidative stress-induced cell death,” Journal of Membrane Biology, vol. 209, no. 1, pp. 31–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Jiang, Z. M. Zhang, L. Liu, C. Zhang, Y. L. Zhang, and Z. C. Zhang, “Effects of Ca2+ channel blockers on store-operated Ca2+ channel currents of Kupffer cells after hepatic ischemia /reperfusion injury in rats,” World Journal of Gastroenterology, vol. 12, no. 29, pp. 4694–4698, 2006. View at Google Scholar · View at Scopus
  43. G. J. Barritt, J. Chen, and G. Y. Rychkov, “Ca2+-permeable channels in the hepatocyte plasma membrane and their roles in hepatocyte physiology,” Biochimica et Biophysica Acta, vol. 1783, no. 5, pp. 651–672, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. P. K. Janicki, P. E. Wise, A. E. Belous, and C. W. Pinson, “Interspecies differences in hepatic Ca2+ -ATPase activity and the effect of cold preservation on porcine liver Ca2+ -ATPase function,” Liver Transplantation, vol. 7, no. 2, pp. 132–139, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. C. D. Anderson, J. Pierce, I. Nicoud, A. Belous, C. D. Knox, and R. S. Chari, “Modulation of mitochondrial calcium management attenuates hepatic warm ischemia-reperfusion injury,” Liver Transplantation, vol. 11, no. 6, pp. 663–668, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. C. D. Knox, J. M. Pierce, I. B. Nicoud et al., “Inhibition of phospholipase C attenuates liver mitochondrial calcium overload following cold ischemia,” Transplantation, vol. 81, no. 4, pp. 567–572, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. A. E. Belous, C. M. Jones, A. Wakata et al., “Mitochondrial calcium transport is regulated by P2Y1- and P2Y2-like mitochondrial receptors,” Journal of Cellular Biochemistry, vol. 99, no. 4, pp. 1165–1174, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Zhao, G. M. Zhao, D. Wu et al., “Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury,” Journal of Biological Chemistry, vol. 279, no. 33, pp. 34682–34690, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Jaeschke and J. J. Lemasters, “Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury,” Gastroenterology, vol. 125, no. 4, pp. 1246–1257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. D. B. Zorov, M. Juhaszova, Y. Yaniv, H. B. Nuss, S. Wang, and S. J. Sollott, “Regulation and pharmacology of the mitochondrial permeability transition pore,” Cardiovascular Research, vol. 83, no. 2, pp. 213–225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. J. J. Lemasters, T. P. Theruvath, Z. Zhong, and A. L. Nieminen, “Mitochondrial calcium and the permeability transition in cell death,” Biochimica et Biophysica Acta, vol. 1787, no. 11, pp. 1395–1401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. S. P. Elmore, T. Qian, S. F. Grissom, and J. J. Lemasters, “The mitochondrial permeability transition initiates autophagy in rat hepatocytes,” The FASEB Journal, vol. 15, no. 12, pp. 2286–2287, 2001. View at Google Scholar · View at Scopus
  53. I. Kim, S. Rodriguez-Enriquez, and J. J. Lemasters, “Selective degradation of mitochondria by mitophagy,” Archives of Biochemistry and Biophysics, vol. 462, no. 2, pp. 245–253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. J. S. Kim, T. Qian, and J. J. Lemasters, “Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes,” Gastroenterology, vol. 124, no. 2, pp. 494–503, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Wang, K. Dou, Z. Song, and Z. Liu, “The Na(+)/H(+) exchange inhibitor: a new therapeutic approach for hepatic ischemia injury in rats,” Transplantation Proceedings, vol. 35, no. 8, pp. 3134–3135, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Carini, M. G. De Cesaris, R. Splendore, M. Bagnati, G. Bellomo, and E. Albano, “Alterations of Na+ homeostasis in hepatocyte reoxygenation injury,” Biochimica et Biophysica Acta, vol. 1500, no. 3, pp. 297–305, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Vairetti, P. Richelmi, F. Bertè, R. T. Currin, J. J. Lemasters, and R. Imberti, “Role of pH in protection by low sodium against hypoxic injury in isolated perfused rat livers,” Journal of Hepatology, vol. 44, no. 5, pp. 894–901, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Caban, G. Oczkowicz, O. Abdel-Samad, and L. Cierpka, “Influence of Kupffer cells on the early phase of liver reperfusion,” Transplantation Proceedings, vol. 34, no. 2, pp. 694–697, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Bruns, I. Watanpour, M. M. Gebhard et al., “Glycine and taurine equally prevent fatty livers from Kupffer cell-dependent injury: an in Vivo microscopy study,” Microcirculation, vol. 18, no. 3, pp. 205–213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Schemmer, R. Schoonhoven, J. A. Swenberg, H. Bunzendahl, and R. G. Thurman, “Gentle in situ liver manipulation during organ harvest decreases survival after rat liver transplantation: role of Kupffer cells,” Transplantation, vol. 65, no. 8, pp. 1015–1020, 1998. View at Publisher · View at Google Scholar · View at Scopus
  61. R. W. Brock, R. G. Nie, K. A. Harris, and R. F. Potter, “Kupffer cell-initiated remote hepatic injury following bilateral hindlimb ischemia is complement dependent,” American Journal of Physiology, vol. 280, no. 2, pp. G279–G284, 2001. View at Google Scholar · View at Scopus
  62. C. Fondevila, X. D. Shen, S. Tsuchihashi et al., “The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury,” Liver Transplantation, vol. 14, no. 8, pp. 1133–1141, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Llacuna, M. Marí, J. M. Lluis, C. García-Ruiz, J. C. Fernández-Checa, and A. Morales, “Reactive oxygen species mediate liver injury through parenchymal nuclear factor-κB inactivation in prolonged ischemia/reperfusion,” American Journal of Pathology, vol. 174, no. 5, pp. 1776–1785, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Hanschen, S. Zahler, F. Krombach, and A. Khandoga, “Reciprocal activation between CD4+ T cells and Kupffer cells during hepatic ischemia-reperfusion,” Transplantation, vol. 86, no. 5, pp. 710–718, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Taniai, I. N. Hines, S. Bharwani et al., “Susceptibility of murine periportal hepatocytes to hypoxia-reoxygenation: role for NO and Kupffer cell-derived oxidants,” Hepatology, vol. 39, no. 6, pp. 1544–1552, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Nakano, T. Kondo, R. Matsuo et al., “Platelet dynamics in the early phase of postischemic liver in vivo,” Journal of Surgical Research, vol. 149, no. 2, pp. 192–198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Khandoga, J. S. Kessler, M. Hanschen et al., “Matrix metalloproteinase-9 promotes neutrophil and T cell recruitment and migration in the postischemic liver,” Journal of Leukocyte Biology, vol. 79, no. 6, pp. 1295–1305, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. C. C. Caldwell, J. Tschoep, and A. B. Lentsch, “Lymphocyte function during hepatic ischemia/reperfusion injury,” Journal of Leukocyte Biology, vol. 82, no. 3, pp. 457–464, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Kuboki, N. Sakai, J. Tschöp, M. J. Edwards, A. B. Lentsch, and C. C. Caldwell, “Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury,” American Journal of Physiology, vol. 296, no. 5, pp. G1054–G1059, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. C. M. Lappas, Y. J. Day, M. A. Marshall, V. H. Engelhard, and J. Linden, “Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation,” Journal of Experimental Medicine, vol. 203, no. 12, pp. 2639–2648, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Khandoga, M. Hanschen, J. S. Kessler, and F. Krombach, “CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets,” Hepatology, vol. 43, no. 2, pp. 306–315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Froh, Z. Zhong, P. Walbrun et al., “Dietary glycine blunts liver injury after bile duct ligation in rats,” World Journal of Gastroenterology, vol. 14, no. 39, pp. 5996–6003, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. N. Selzner, M. Selzner, B. Odermatt, Y. Tian, N. Van Rooijen, and P. A. Clavien, “ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-α/IL-6 in mice,” Gastroenterology, vol. 124, no. 3, pp. 692–700, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. O. Gressner, T. Schilling, K. Lorenz et al., “TAp63α induces apoptosis by activating signaling via death receptors and mitochondria,” EMBO Journal, vol. 24, no. 13, pp. 2458–2471, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. C. Peralta, L. Fernández, J. Panés et al., “Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat,” Hepatology, vol. 33, no. 1, pp. 100–113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  76. H. A. Rüdiger and P. Clavien, “Tumor necrosis factor α, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver,” Gastroenterology, vol. 122, no. 1, pp. 202–210, 2002. View at Google Scholar · View at Scopus
  77. M. Müller, S. Strand, H. Hug et al., “Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO- 1/Fas) receptor/ligand system and involves activation of wild-type p53,” Journal of Clinical Investigation, vol. 99, no. 3, pp. 403–413, 1997. View at Google Scholar · View at Scopus
  78. M. Müller, S. Wilder, D. Bannasch et al., “p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs,” Journal of Experimental Medicine, vol. 188, no. 11, pp. 2033–2045, 1998. View at Publisher · View at Google Scholar · View at Scopus
  79. S. T. Eichhorst, M. Muller, M. Li-Weber, H. Schulze-Bergkamen, P. Angel, and P. H. Krammer, “A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs,” Molecular and Cellular Biology, vol. 20, no. 20, pp. 7826–7837, 2000. View at Publisher · View at Google Scholar · View at Scopus
  80. B. Li, B. Chen, G. Zhang, K. Wang, L. Zhou, and S. Hu, “Cell apoptosis and fas gene expression in liver and renal tissues after ischemia-reperfusion injury in liver transplantation,” Transplantation Proceedings, vol. 42, no. 5, pp. 1550–1556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. C. A. Bradham, P. Schemmer, R. F. Stachlewitz, R. G. Thurman, and D. A. Brenner, “Activation of nuclear factor-κB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells,” Liver Transplantation and Surgery, vol. 5, no. 4, pp. 282–293, 1999. View at Google Scholar · View at Scopus
  82. R. F. Schwabe and D. A. Brenner, “Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways,” American Journal of Physiology, vol. 290, no. 4, pp. G583–G589, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. R. Liang, A. Nickkholgh, K. Hoffmann et al., “Melatonin protects from hepatic reperfusion injury through inhibition of IKK and JNK pathways and modification of cell proliferation,” Journal of Pineal Research, vol. 46, no. 1, pp. 8–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Sanlioglu, C. M. Williams, L. Samavati et al., “Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-α secretion through IKK regulation of NF-κB,” Journal of Biological Chemistry, vol. 276, no. 32, pp. 30188–30198, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. C. Szabó, H. Ischiropoulos, and R. Radi, “Peroxynitrite: biochemistry, pathophysiology and development of therapeutics,” Nature Reviews Drug Discovery, vol. 6, no. 8, pp. 662–680, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Tsung, R. Sahai, H. Tanaka et al., “The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion,” Journal of Experimental Medicine, vol. 201, no. 7, pp. 1135–1143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. L. E. Pelinka, N. Harada, L. Szalay, M. Jafarmadar, H. Redl, and S. Bahrami, “Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats.,” Shock, vol. 21, no. 1, pp. 72–76, 2004. View at Google Scholar · View at Scopus
  88. J. Zhang, H. Wang, Q. Xiao et al., “Hyaluronic acid fragments evoke Kupffer cells via TLR4 signaling pathway,” Science in China C, vol. 52, no. 2, pp. 147–154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Pardo, N. Budick-Harmelin, B. Tirosh, and O. Tirosh, “Antioxidant defense in hepatic ischemia-reperfusion injury is regulated by damage-associated molecular pattern signal molecules,” Free Radical Biology and Medicine, vol. 45, no. 8, pp. 1073–1083, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. Z. M. Bamboat, V. P. Balachandran, L. M. Ocuin, H. Obaid, G. Plitas, and R. P. DeMatteo, “Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury,” Hepatology, vol. 51, no. 2, pp. 621–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Katsargyris, C. Klonaris, A. Alexandrou, A. E. Giakoustidis, I. Vasileiou, and S. Theocharis, “Toll like receptors in liver ischemia reperfusion injury: a novel target for therapeutic modulation?” Expert Opinion on Therapeutic Targets, vol. 13, no. 4, pp. 427–442, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. T. V. Arumugam, E. Okun, S. C. Tang, J. Thundyil, S. M. Taylor, and T. M. Woodruff, “Toll-like receptors in ischemia-reperfusion injury,” Shock, vol. 32, no. 1, pp. 4–16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. G. Szabo, A. Dolganiuc, and P. Mandrekar, “Pattern recognition receptors: a contemporary view on liver diseases,” Hepatology, vol. 44, no. 2, pp. 287–298, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. S. I. Tsuchihashi, Y. Zhai, Q. Bo, R. W. Busuttil, and J. W. Kupiec-Weglinski, “Heme oxygenase-1 mediated cytoprotection against liver ischemia and reperfusion injury: inhibition of type-1 interferon signaling,” Transplantation, vol. 83, no. 12, pp. 1628–1634, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. H. Wang, Z. Y. Li, H. S. Wu et al., “Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway,” Chinese Medical Journal, vol. 120, no. 6, pp. 509–514, 2007. View at Google Scholar · View at Scopus
  96. Y. Zhai, X. D. Shen, R. O'Connell et al., “Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway,” Journal of Immunology, vol. 173, no. 12, pp. 7115–7119, 2004. View at Google Scholar · View at Scopus
  97. T. Watanabe, S. Kubota, M. Nagaya et al., “The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice,” Journal of Surgical Research, vol. 124, no. 1, pp. 59–66, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. S. Zeng, H. Dun, N. Ippagunta et al., “Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury,” Journal of Hepatology, vol. 50, no. 5, pp. 929–936, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Tsung, N. Zheng, G. Jeyabalan et al., “Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 119–128, 2007. View at Publisher · View at Google Scholar · View at Scopus